Background: Late diagnosis of HIV infection is an important cause of death in children. Objectives: To determine the prevalence of late diagnosed HIV infection in children, describe the socio-demographic characteristics and to analyze outcome of these children. Methods: From January 2015 to October 2016, we carried out a prospective analytical study in the pediatric departments of University Teaching Hospital of the Brazzaville. Late diagnosed HIV children were selected for this work. Data analysis was performed in univariate and multivariate with Epi Info 7.2.1. Results: Of the 6058 hospitalized children, 103 (1.7%) were selected, 57.3% were boys; the median age was 21.9 months (IQR, 17.8 -76.7 months). Children of low socio-economic status accounted for 68.0%, those motherless: 43.7%. None of the children were tested for HIV before hospitalization. Mothers had a low education level in 60.2% of cases and were unaware of prevention of mother-to-child transmission (PMTCT): 60.3%. Children mostly showed signs of stages 4 (49.5%), and 3 (31.1%) of HIV infection, immunodeficiency was severe for 68.0% of children. Children discharged from the hospital accounted for 62.1% of which 15.53% against medical advice. The case fatality rate was 37.9%. The risk factors for death in univariate analysis were: age < 12 months (OR = 8.66), maternal death (OR = 17.93), severe malnutrition (OR = 66.07), clinical stages 4 (OR = 66.07) and severe immunodeficiency (OR = 17.37). The main pathologies responsible for death were respiratory infections (38.5%) and diarrheal diseases (30
Introduction
Human Immunodeficiency Virus (HIV) infection described for the first time in children in the 80 s [1] , has had different epidemiological evolution depending on the regions and countries. In high income countries, after a critical period, the epidemiological situation has changed drastically: mother-to-child transmission of HIV infection has almost been eliminated through an effective prevention policy, morbidity and mortality have been significantly reduced by the early and wide use of high-activity antiretroviral therapy (HAART) in children [2] [3] . In low and middle income countries, especially those located in sub-Saharan Africa, despite the successes in the response to HIV infection, it still contributes significantly to the childhood morbidity and mortality [4] [5] ; In 2016, UNAIDS estimated that 2.1 million children under 15 years were living with HIV, among whom 160,000 new cases and nearly 90% of these children were in sub-Saharan Africa.
Of the estimated 1.0 million people who died of AIDS-related illnesses in 2016, 120,000 of them were children under 15 years of age and the vast majority of these deaths occur in sub-Saharan Africa [5] . One of the main causes of HIV-related morbidity and mortality still high in Africa is late diagnosis and consequently late initiation of antiretroviral therapy (ART) [6] . Indeed several studies highlight the survival benefit of early initiation of antiretroviral therapy for HIV-infected infants especially when ART was initiated before the clinical signs and symptoms of HIV infection [6] [7] [8] . And based on these data, the WHO has changed its treatment recommendations, calling for treatment of all infected infants under 24 months of age, irrespective of clinical stage and CD4 count; To improve early access to pediatric antiretroviral therapy, WHO recommends that countries with high incidence should ensure scaling up of program services prevention of mother-to-child transmission (PMTCT) of HIV infection and routine early detection infant [9] . Despite these recommendations, the number of HIV-children diagnosed late in hospital remains high in Africa [10] [11] . The proportion of late diagnosed HIV-infected children is also a good indicator of the effectiveness of HIV-related services in a country, especially prevention and screening. In Congo, child data are rare, in 2016, UNAIDS estimated that 6000 children living with HIV, 1100 newly infected children, and HIV infection is one of the main causes of death in children with nearly 1000 deaths [12] [13] . Furthermore, the prevalence of HIV infection remains high among pregnant women, the knowledge of the PMTCT program by them is poor and coverage of PMTCT services is low [12] [14] . Additionally, early detection was only performed in 3% of PMTCT in- 
Study Design and Patients
We carried out a prospective analytical study between January 2015 and July 2016. [19] were included systematically and consecutively.
Data Collection
We recorded all data on a standardized and structured form. 
Definitions

Statistical Analysis
The data was processed and analyzed with Epi info 7.2.1 software. Quantitative variables were expressed in median and interquartile range (IQR) and qualitative variables in percent. The numbers of each variable were also specified. The percentages were compared with the independence Chi-2 test or the Fischer test (when at least one of the theoretical numbers was less than 5) and the odds ratio (OR). In the multivariate logistic regression model, we included only variables significantly associated with death from the univariate analysis (p ≤ 0.20). The significance level was set at 5% and the 95% confidence interval (CI).
Ethical Considerations
We obtained informed consent from parents/caregivers for interviews. The study was conducted in compliance with the Helsinki Declaration [23] . The study was approved by the National Ethics Committee.
Results
Description of the Population
From January 2015 to July 2016, 6058 children were hospitalized to UTH, among them 103 (1.7%) HIV-infected children, all of whom meet the criteria for late diagnosed HIV infection and were included in our study (the patient selection flow diagram is shown in Figure 1 ). There were 59 boys (57.3%) and the sex ratio was 1.3. median age was 21.9 months (IQR, 17.8 -76.7 months). Forty-five (43.7%) children were orphaned by mother. The reasons of maternal deaths have not been formally identified; however, close relatives have often described HIV related reasons.
The socio-demographic, clinical and evolutionary characteristics of the population are detailed in Table 1 . None of the children were tested for HIV before hospitalization, even those whose mothers were diagnosed with HIV during pregnancy. 
Knowledge and Practices
Causes of Hospitalization
The main causes of hospitalization were bronchopulmonary infections, which accounted for 51.5% of cases (including pulmonary tuberculosis) and diarrheal diseases (39.8%) (Figure 2 ).
Outcome
Among the 103 children identified, 48 (46.6%) were discharged with ART, sixteen children (15.53%) went out against medical advice. for 39 children (37.9%), the evolution was towards a death. The median duration of hospital stay was 9
days (IQR, 6 -14 days).
The risk factors for death was identified only in univariate analysis, the multivariate analysis showed no risk factors independently associated with death ( Table 2 ).
The pathologies responsible for death were: bronchopulmonary infections n = 15 (38.5%), diarrheal diseases n = 12 (30.8%), pulmonary tuberculosis n = 4, malaria n = 3, meningitis and encephalitis 2 cases each and anemia 1 case. Research in Community Health) project [36] . To meet these challenges will no doubt require investment in key areas such as training and support for child health professionals, improvement of laboratory facilities and referral networks, and community mobilization.
Discussion
HIV infection in this work was often early-onset, 36.9% of children less than 1 year old and the majority less than 2 years old at the time of diagnosis. The high incidence of early clinical form of HIV infection in children in Africa is a known fact [37] [38] and requires the implementation of an effective screening strategy to identify these infected infants prior disease progression. The antenatal and per-partum contamination associated with the very advanced state of infection in the mothers, as suggested by the high maternal mortality rate in our study, the multiple deficiencies in the mother and in the child are the main reasons for this high fre- recommends initiating ART as soon as possible after the diagnosis of HIV infection in children and routinely in HIV-infected infants under 2 years of age [9] .
The Congo has adopted these recommendations, but is still slow to ensure that these recommendations are scaled up.
The risk factors for death identified in univariate analysis in this work are identical to those reported by other authors [47] [48], most of whom are directly or indirectly related to the severity of the clinical symptomatology. With regard to maternal death, it increases the vulnerability of these children because of precarity, lack of love, and maternal attention and sometimes lack of care. No risk factors independently associated with death were found in the multivariate analysis.
Caution is however needed when interpreting these results, since sample size was small and likely insufficient to detect significant differences among deceased group and survivals group.
Limitations
This work presents some limitations, the first concerns the site of the study, the fact that it was performed in a single hospital makes it difficult to extrapolate the 
Implications
Despite its limitations, this study is the first on this subject since the implementation of PMTCT and setting up free healthcare for HIV in Congo and our findings draw the attention of health authorities and health professionals to the importance of late diagnosis of HIV infection in HIV-related morbidity and mortality in Brazzaville and probably in many cities in sub-Saharan Africa, to emphasize the value of early diagnosis and treatment of HIV infection in children for reducing mortality, and finally to describe the factors that contribute to late diagnosis.
Conclusion
Late diagnosed HIV infection remains common and causes heavy mortality in children in Brazzaville. Congo should build capacity in its PMTCT program, but also implement an effective strategy for routine early detection of HIV infection and treatment of infected children to reduce prevalence, improve diagnosis of infection HIV and therefore reduce HIV-related morbidity and mortality in children.
